Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Ross E Staudt, Robert D Carlson & Adam E Snook. (2022) Targeting gastrointestinal cancers with chimeric antigen receptor (CAR)-T cell therapy. Cancer Biology & Therapy 23:1, pages 127-133.
Read now
Read now
Agnes Ling, Anna Löfgren-Burström, Pär Larsson, Xingru Li, Maria L. Wikberg, Åke Öberg, Roger Stenling, Sofia Edin & Richard Palmqvist. (2017) TAP1 down-regulation elicits immune escape and poor prognosis in colorectal cancer. OncoImmunology 6:11.
Read now
Read now
Qi Zhang, Zimu Zhang, Meiyu Peng, Shuyu Fu, Zhenyi Xue & Rongxin Zhang. (2016) CAR-T cell therapy in gastrointestinal tumors and hepatic carcinoma: From bench to bedside. OncoImmunology 5:12.
Read now
Read now
Mostafa Haji-Fatahaliha, Maryam Hosseini, Asiye Akbarian, Sanam Sadreddini, Farhad Jadidi-Niaragh & Mehdi Yousefi. (2016) CAR-modified T-cell therapy for cancer: an updated review. Artificial Cells, Nanomedicine, and Biotechnology 44:6, pages 1339-1349.
Read now
Read now
Maureen L Drakes & Patrick J Stiff. (2014) Harnessing immunosurveillance: current developments and future directions in cancer immunotherapy. ImmunoTargets and Therapy 3, pages 151-165.
Read now
Read now
Barbara Seliger. (2014) The link between MHC class I abnormalities of tumors, oncogenes, tumor suppressor genes, and transcription factors. Journal of Immunotoxicology 11:4, pages 308-310.
Read now
Read now
Articles from other publishers (42)
Anna Helmin-Basa, Lidia Gackowska, Sara Balcerowska, Marcelina Ornawka, Natalia Naruszewicz & Małgorzata Wiese-Szadkowska. (2022) The application of the natural killer cells, macrophages and dendritic cells in treating various types of cancer. Physical Sciences Reviews 7:8, pages 833-866.
Crossref
Crossref
Natalia Janicka, Agnieszka Sałek, Magdalena Sawińska, Ernest Kuchar, Anna Wiela-Hojeńska & Katarzyna Karłowicz-Bodalska. (2022) Effects of Non-Opioid Analgesics on the Cell Membrane of Skin and Gastrointestinal Cancers. International Journal of Molecular Sciences 23:13, pages 7096.
Crossref
Crossref
Theodoros Michelakos, Filippos Kontos, Tomohiro Kurokawa, Lei Cai, Ananthan Sadagopan, Danielle Krijgsman, Wilko Weichert, Lindy G Durrant, Peter J K Kuppen, Cristina R Ferrone & Soldano Ferrone. (2022) Differential role of HLA-A and HLA-B, C expression levels as prognostic markers in colon and rectal cancer. Journal for ImmunoTherapy of Cancer 10:3, pages e004115.
Crossref
Crossref
Shogo Kumagai, Shohei Koyama & Hiroyoshi Nishikawa. (2021) Antitumour immunity regulated by aberrant ERBB family signalling. Nature Reviews Cancer 21:3, pages 181-197.
Crossref
Crossref
Jeffrey C Thompson, Christiana Davis, Charuhas Deshpande, Wei-Ting Hwang, Seth Jeffries, Alexander Huang, Tara C Mitchell, Corey J Langer & Steven M Albelda. (2020) Gene signature of antigen processing and presentation machinery predicts response to checkpoint blockade in non-small cell lung cancer (NSCLC) and melanoma. Journal for ImmunoTherapy of Cancer 8:2, pages e000974.
Crossref
Crossref
Laura Sanz-Ortega, José Manuel Rojas & Domingo F. Barber. (2020) Improving Tumor Retention of Effector Cells in Adoptive Cell Transfer Therapies by Magnetic Targeting. Pharmaceutics 12:9, pages 812.
Crossref
Crossref
Daniel Baumann, Tanja Hägele, Julian Mochayedi, Jennifer Drebant, Caroline Vent, Sven Blobner, Julia Han Noll, Irena Nickel, Corinna Schumacher, Sophie Luise Boos, Aline Sophie Daniel, Susann Wendler, Michael Volkmar, Oliver Strobel & Rienk Offringa. (2020) Proimmunogenic impact of MEK inhibition synergizes with agonist anti-CD40 immunostimulatory antibodies in tumor therapy. Nature Communications 11:1.
Crossref
Crossref
Evangelos Koustas, Panagiotis Sarantis, Athanasios G. Papavassiliou & Michalis V. Karamouzis. (2020) The Resistance Mechanisms of Checkpoint Inhibitors in Solid Tumors. Biomolecules 10:5, pages 666.
Crossref
Crossref
Yuehong Chen, Jianhong Sun, Huan Liu, Geng Yin & Qibing Xie. (2019) Immunotherapy Deriving from CAR-T Cell Treatment in Autoimmune Diseases. Journal of Immunology Research 2019, pages 1-9.
Crossref
Crossref
Michael Friedrich, Simon Jasinski-Bergner, Maria-Filothei Lazaridou, Karthikeyan Subbarayan, Chiara Massa, Sandy Tretbar, Anja Mueller, Diana Handke, Katharina Biehl, Jürgen Bukur, Marco Donia, Ofer Mandelboim & Barbara Seliger. (2019) Tumor-induced escape mechanisms and their association with resistance to checkpoint inhibitor therapy. Cancer Immunology, Immunotherapy 68:10, pages 1689-1700.
Crossref
Crossref
Sohinee Bhattacharyya & Anindit Mukherjee. 2019. Biotechnology Products in Everyday Life. Biotechnology Products in Everyday Life
101
115
.
Jinjing Xu, Yali Wang, Jing Shi, Juan Liu, Qingguo Li & Longzhou Chen. (2018) Combination therapy: A feasibility strategy for CAR‑T cell therapy in the treatment of solid tumors (Review). Oncology Letters.
Crossref
Crossref
Diogo Gomes-Silva & Carlos A. Ramos. (2018) Cancer Immunotherapy Using CAR-T Cells: From the Research Bench to the Assembly Line. Biotechnology Journal 13:2, pages 1700097.
Crossref
Crossref
Locke D. Uppendahl, Carly M. Dahl, Jeffrey S. Miller, Martin Felices & Melissa A. Geller. (2018) Natural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A Review. Frontiers in Immunology 8.
Crossref
Crossref
Greta Garrido, Ailem Rabasa, Cristina Garrido, Lisset Chao, Federico Garrido, Ángel M. García-Lora & Belinda Sánchez-Ramírez. (2017) Upregulation of HLA Class I Expression on Tumor Cells by the Anti-EGFR Antibody Nimotuzumab. Frontiers in Pharmacology 8.
Crossref
Crossref
Timothy E. Richardson, Zhong-Jian Shen, Mohammed Kanchwala, Chao Xing, Alexander Filatenkov, Ping Shang, Samuel Barnett, Zahidur Abedin, James S. Malter, Jack M. Raisanen, Dennis K. Burns, Charles L. White & Kimmo J. Hatanpaa. (2017) Aggressive Behavior in Silent Subtype III Pituitary Adenomas May Depend on Suppression of Local Immune Response: A Whole Transcriptome Analysis. Journal of Neuropathology & Experimental Neurology 76:10, pages 874-882.
Crossref
Crossref
Jennifer D. Moy, Jessica M. Moskovitz & Robert L. Ferris. (2017) Biological mechanisms of immune escape and implications for immunotherapy in head and neck squamous cell carcinoma. European Journal of Cancer 76, pages 152-166.
Crossref
Crossref
Shuanglin Han, Olivier Latchoumanin, Guang Wu, Gang Zhou, Lionel Hebbard, Jacob George & Liang Qiao. (2017) Recent clinical trials utilizing chimeric antigen receptor T cells therapies against solid tumors. Cancer Letters 390, pages 188-200.
Crossref
Crossref
S. V. Kulemzin, N. A. Chikaev, O. Y. Volkova, V. V. Kuznetsova, A. V. Taranin & A. A. Gorchakov. (2017) Modular lentiviral vector system for chimeric antigen receptor design optimization. Russian Journal of Bioorganic Chemistry 43:2, pages 107-114.
Crossref
Crossref
Abir K. Panda, Sreeparna Chakraborty, Kirti Kajal, Dia Roy, Tania Sarkar & Gaurisankar Sa. 2017. Pathophysiological Aspects of Proteases. Pathophysiological Aspects of Proteases
265
296
.
T. Huibertus van Essen, Sake I. van Pelt, Inge H. G. Bronkhorst, Mieke Versluis, Fariba Némati, Cécile Laurent, Gregorius P. M. Luyten, Thorbald van Hall, Peter J. van den Elsen, Pieter A. van der Velden, Didier Decaudin & Martine J. Jager. (2016) Upregulation of HLA Expression in Primary Uveal Melanoma by Infiltrating Leukocytes. PLOS ONE 11:10, pages e0164292.
Crossref
Crossref
Anna E. Kersh, Maiko Sasaki, Lee A. Cooper, Haydn T. Kissick & Brian P. Pollack. (2016) Understanding the Impact of ErbB Activating Events and Signal Transduction on Antigen Processing and Presentation: MHC Expression as a Model. Frontiers in Pharmacology 7.
Crossref
Crossref
Binh Thanh Vu, Dat Tan Le & Phuc Van Pham. (2016) Synergistic effect of chimeric antigen receptors and cytokineinduced killer cells: An innovative combination for cancer therapy. Biomedical Research and Therapy 3:6.
Crossref
Crossref
Frédéric Ebstein, Martin Keller, Annette Paschen, Peter Walden, Michael Seeger, Elke Bürger, Elke Krüger, Dirk Schadendorf, Peter-M. Kloetzel & Ulrike Seifert. (2016) Exposure to Melan-A/MART-126-35 tumor epitope specific CD8+T cells reveals immune escape by affecting the ubiquitin-proteasome system (UPS). Scientific Reports 6:1.
Crossref
Crossref
Sofia R. Gameiro, Anthony S. Malamas, Kwong Y. Tsang, Soldano Ferrone & James W. Hodge. (2016) Inhibitors of histone deacetylase 1 reverse the immune evasion phenotype to enhance T-cell mediated lysis of prostate and breast carcinoma cells. Oncotarget 7:7, pages 7390-7402.
Crossref
Crossref
Deimante Tamkus & Tejaswini Joginpally. (2016) Therapeutic strategies to reverse immunosuppressive breast cancer microenvironment. Oncology Discovery 4:1, pages 1.
Crossref
Crossref
Malgorzata Wachowska, Angelika Muchowicz & Jakub Golab. (2015) Targeting Epigenetic Processes in Photodynamic Therapy-Induced Anticancer Immunity. Frontiers in Oncology 5.
Crossref
Crossref
Ji Sung KimYong Guk KimMinji PyoHong Kyung LeeJin Tae HongYoungsoo KimSang-Bae Han. (2015) Adoptive Cell Therapy of Melanoma with Cytokine-induced Killer Cells. Immune Network 15:2, pages 58.
Crossref
Crossref
X Pu, M A T Hildebrandt, C Lu, J A Roth, D J Stewart, Y Zhao, R S Heist, Y Ye, D W Chang, L Su, J D Minna, S M Lippman, M R Spitz, D C Christiani & X Wu. (2014) Inflammation-Related Genetic Variations and Survival in Patients With Advanced Non–Small Cell Lung Cancer Receiving First-Line Chemotherapy. Clinical Pharmacology & Therapeutics 96:3, pages 360-369.
Crossref
Crossref
David Kosoff, Timothy Krueger & Joshua M Lang. (2013) Targeting epigenetic mechanisms for clinical translation: enhancing the efficacy of tumor immunotherapies. Immunotherapy 5:11, pages 1243-1254.
Crossref
Crossref
Naomi Ohta, Atsushi Kawabata, Deepthi Uppalapati, Susumu Ishiguro, Deryl Troyer & Masaaki Tamura. 2013. Stem Cell Therapeutics for Cancer. Stem Cell Therapeutics for Cancer
111
126
.
Maximilian Müller, Abbas Agaimy, Johannes Zenk, Tobias Ettl, Heinrich Iro, Arndt Hartmann, Barbara Seliger & Stephan Schwarz. (2013)
The prognostic impact of human leukocyte antigen (
HLA
) class I antigen abnormalities in salivary gland cancer. A clinicopathological study of 288 cases
. Histopathology 62:6, pages 847-859.
Crossref
Crossref
Kevin J. Curran, Hollie J. Pegram & Renier J. Brentjens. (2012) Chimeric antigen receptors for T cell immunotherapy: current understanding and future directions. The Journal of Gene Medicine 14:6, pages 405-415.
Crossref
Crossref
Melissa A Geller & Jeffrey S Miller. (2011) Use of allogeneic NK cells for cancer immunotherapy. Immunotherapy 3:12, pages 1445-1459.
Crossref
Crossref
Yeranddy A. Alpizar, Benjamin Chain, Mary K. Collins, John Greenwood, David Katz, Hans J. Stauss & N. Avrion Mitchison. (2011) Ten years of progress in vaccination against cancer: the need to counteract cancer evasion by dual targeting in future therapies. Cancer Immunology, Immunotherapy 60:8, pages 1127-1135.
Crossref
Crossref
Dagmar Quandt, Eckhard Fiedler, Diana Boettcher, Wolfgang Ch Marsch & Barbara Seliger. (2011) B7-H4 Expression in Human Melanoma: Its Association with Patients' Survival and Antitumor Immune Response. Clinical Cancer Research 17:10, pages 3100-3111.
Crossref
Crossref
Michael S. Leibowitz, Pedro A. Andrade Filho, Soldano Ferrone & Robert L. Ferris. (2011) Deficiency of activated STAT1 in head and neck cancer cells mediates TAP1-dependent escape from cytotoxic T lymphocytes. Cancer Immunology, Immunotherapy 60:4, pages 525-535.
Crossref
Crossref
Claus S Sondergaard, David A Hess, Dustin J Maxwell, Carla Weinheimer, Ivana Rosová, Michael H Creer, David Piwnica-Worms, Attila Kovacs, Lene Pedersen & Jan A Nolta. (2010) Human cord blood progenitors with high aldehyde dehydrogenase activity improve vascular density in a model of acute myocardial infarction. Journal of Translational Medicine 8:1.
Crossref
Crossref
M Meissner, V König, I Hrgovic, E Valesky & R Kaufmann. (2010) Human leucocyte antigen class I and class II antigen expression in malignant fibrous histiocytoma, fibrosarcoma and dermatofibrosarcoma protuberans is significantly downregulated. Journal of the European Academy of Dermatology and Venereology 24:11, pages 1326-1332.
Crossref
Crossref
Qian Jiang, Hong-ya Pan, Dong-xia Ye, Ping Zhang, Lai-ping Zhong & Zhi-yuan Zhang. (2010) Downregulation of tapasin expression in primary human oral squamous cell carcinoma: association with clinical outcome. Tumor Biology 31:5, pages 451-459.
Crossref
Crossref
L Endo-Munoz, A Cumming, S Sommerville, I Dickinson & N A Saunders. (2010) Osteosarcoma is characterised by reduced expression of markers of osteoclastogenesis and antigen presentation compared with normal bone. British Journal of Cancer 103:1, pages 73-81.
Crossref
Crossref
Marc Cartellieri, Michael Bachmann, Anja Feldmann, Claudia Bippes, Slava Stamova, Rebekka Wehner, Achim Temme & Marc Schmitz. (2010) Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Cancer. Journal of Biomedicine and Biotechnology 2010, pages 1-13.
Crossref
Crossref